Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.07M Buy
7,329
+3
+0% +$415 0.31% 88
2026
Q2
$941K Sell
7,326
-1
-0% -$117 0.27% 92
2026
Q1
$881K Sell
7,327
-159
-2% -$18.4K 0.31% 85
2025
Q4
$788K Sell
7,486
-135
-2% -$12.7K 0.28% 88
2025
Q3
$640K Sell
7,621
-53
-0.7% -$4.36K 0.24% 98
2025
Q2
$608K Buy
7,674
+512
+7% +$40.7K 0.24% 98
2025
Q1
$643K Buy
+7,162
New +$669K 0.27% 86
2024
Q4
– Sell
-21,405
Closed -$2.43M – 129
2024
Q3
$2.43M Buy
21,405
+545
+3% +$64.7K 1.02% 36
2024
Q2
$2.67M Buy
20,860
+10,564
+103% +$1.36M 1.16% 30
2024
Q1
$1.36M Buy
+10,296
New +$1.27M 0.61% 52
2020
Q1
– Sell
-46,684
Closed -$4.05M – 221
2019
Q4
$4.05M Buy
+46,684
New +$3.83M 2.29% 15
2019
Q1
– Sell
-84
Closed -$6K – 236
2018
Q4
$6K Buy
+84
New +$5.93K 0.01% 176
2018
Q1
– Sell
-5,554
Closed -$298K – 206
2017
Q4
$298K Buy
+5,554
New +$308K 0.22% 71

Other funds holding MRK

G&S Capital's MRK Position: Q3 2026 in Review

G&S Capital increased its Merck (MRK) stake by 0.04% in Q3 2026, buying an estimated $415 and bringing the position to 7,329 shares worth $1.07M. The position accounts for 0.31% of the portfolio, ranked #88.

G&S Capital first reported a position in MRK in Q4 2017 and has held it in 13 quarters since. The position peaked at $4.05M in Q4 2019. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • G&S Capital held 7,329 shares of Merck worth $1.07M as of Q3 2026.
  • G&S Capital bought 3 Merck shares in Q3 2026, an estimated $415.
  • Merck made up 0.31% of G&S Capital's portfolio in Q3 2026, its #88 holding.
  • G&S Capital first reported a position in Merck in Q4 2017 and has held it in 13 quarters since.
  • G&S Capital's Merck position peaked at $4.05M in Q4 2019.
  • 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on G&S Capital's 13F filing for Q3 2026, filed 23 Oct 2026.